Filter By Category
Archives
Share on -
BOFANGLUTIDE
Generic Name: BOFANGLUTIDE
ABSTRACT -
Bofanglutide is a peptide or peptide-like API described as a long-acting glucagon-like peptide-1 receptor agonist. Its identity is defined by amino-acid sequence, modifications, counter-ion/salt form, purity profile, and biological activity.
DOSAGE -
Dosing depends on formulation, route, indication, and clinical protocol. Peptide products may require injection-site monitoring and storage handling according to the product specification.
SIDE EFFECTS-
Common or possible side effects may include:
- Injection-site pain, redness, or swelling
- Nausea, vomiting, or gastrointestinal discomfort
- Headache, dizziness, or fatigue
- Hypersensitivity reactions
- Target-related endocrine or inflammatory effects
ALLERGIC REACTIONS -
Allergic or hypersensitivity reactions may occur and require medical attention.
- Skin rash, hives, itching, or flushing
- Swelling of the face, lips, tongue, throat, or injection/infusion site
- Wheezing, chest tightness, shortness of breath, or severe dizziness
- Fever, chills, blistering, severe skin reaction, or collapse
DRUG INTERACTIONS-
Review concomitant medicines for overlapping toxicity and protocol restrictions
PREAUTONS–
- Confirm API identity, formulation, route, strength, and intended indication before use
- Review allergy history and prior serious adverse reactions
WARNINGS –
Use only under qualified healthcare supervision and according to applicable protocol
Share on -
. Developed by